Clinical trial
Screening Protocol for HIV Vaccine Studies
NCT00031304 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00031304 |
|---|---|
| Title | Screening Protocol for HIV Vaccine Studies |
| Official title | Screening Subjects for HIV Vaccine Research Studies |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Seronegativity, HIV Infections |
| Enrollment | 1,324 |
| Start date | Feb 27, 2002 |
| Completion | Apr 8, 2013 |
| First posted | Mar 1, 2002 |
| Last update posted | Dec 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: